Willingness to pay for diagnostic technologies: A review of the contingent valuation literature

Value in Health

Volumn 16, Issue 5, 2013, Pages 797-805

  Lin, Pei Jung ^a   Cangelosi, Michael J ^a   Lee, David W ^b   Neumann, Peter J ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

contingent valuation; diagnostics; review; willingness to pay

Indexed keywords

ARTICLE; COLON CANCER; COLORECTAL CANCER; CONTINGENT VALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; EDUCATIONAL STATUS; FAMILY HISTORY; GENETIC SCREENING; HEALTH CARE COST; HUMAN; INCOME; INFECTION; LABORATORY TEST; MEDICAL TECHNOLOGY; ONCOLOGY; PRIORITY JOURNAL; SCREENING;

CONTINGENT VALUATION; DIAGNOSTICS; REVIEW; WILLINGNESS TO PAY;

CHOICE BEHAVIOR; COSTS AND COST ANALYSIS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FINANCING, PERSONAL; MODELS, ECONOMIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 84881667879     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2013.04.005     Document Type: Article

References (79)

1. A.J. Maitino, D.C. Levin, and L. Parker Nationwide trends in rates of utilization of noninvasive diagnostic imaging among the Medicare population between 1993 and 1999 Radiology 227 2003 113 117
2. B.M. Rothenberg, and A. Korn The opportunities and challenges posed by the rapid growth of diagnostic imaging J Am Coll Radiol 2 2005 407 410
3. A. Qaseem, P. Alguire, and P. Dallas Appropriate use of screening and diagnostic tests to foster high-value, cost-conscious care Ann Intern Med 156 2012 147 149
4. H.J. Otero, F.J. Rybicki, and D. Greenberg Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money? Int J Cardiovasc Imaging 26 2010 605 612
5. D.W. Lee, P.J. Neumann, and J.A. Rizzo Understanding the medical and nonmedical value of diagnostic testing Value Health 13 2010 310 314
6. P.J. Neumann, J.T. Cohen, and J.K. Hammitt Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents Health Econ 21 2012 238 251
7. M.F. Drummond, MJ. Sculpher, and GW. Torrance Contingent Valuation Studies. In: Methods for the Economic Evaluation of Health Care Programmes 3rd ed 2005 Oxford University Press Oxford, UK
8. A. Tarasiuk, T. Simon, and U. Regev Willingness to pay for polysomnography in children with obstructive sleep apnea syndrome: a cost-benefit analysis Sleep 26 2003 1016 1021
9. K. Blumenschein, and M. Johannesson Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature Clin Therapeut 21 1999 1402 1417 discussion 01
10. H. Varian Consumers' Surplus: Microeconomic Analysis 3rd ed 1992 W.W. Norton & Company, Inc. New York, NY
11. A. Diener, B. O'Brien, and A. Gafni Health care contingent valuation studies: a review and classification of the literature Health Econ 7 1998 313 326
12. J. Lachaine Therapeutic options for the prevention and treatment of postoperative nausea and vomiting: a pharmacoeconomic review Pharmacoeconomics 24 2006 955 970
13. J.A. Olsen, and R.D. Smith Theory versus practice: a review of 'willingness-to-pay' in health and health care Health Econ 10 2001 39 52
14. R. Rodriguez-Monguio, M.J. Otero, and J. Rovira Assessing the economic impact of adverse drug effects Pharmacoeconomics 21 2003 623 650
15. T.H. Sach, R.D. Smith, and D.K. Whynes A 'league table' of contingent valuation results for pharmaceutical interventions: a hard pill to swallow? Pharmacoeconomics 25 2007 107 127
16. N.D. Goswami, E. Hecker, and D.P. Holland Feasibility and willingness-to-pay for integrated community-based tuberculosis testing BMC Infect Dis 11 2011 305
17. K.D. Graves, B.N. Peshkin, and G. Luta Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing Public Health Genomics 14 2011 178 189
18. L.B. Pedersen, D. Gyrd-Hansen, and T. Kjaer The influence of information and private versus public provision on preferences for screening for prostate cancer: a willingness-to-pay study Health Policy 101 2011 277 289
19. D. van Helvoort-Postulart, C.D. Dirksen, and A.G. Kessels A comparison between willingness to pay and willingness to give up time Eur J Health Econ 10 2009 81 91
20. S. Wordsworth, M. Ryan, and N. Waugh Costs and benefits of cervical screening, IV: valuation by women of the cervical screening programme Cytopathology 12 2001 367 376
21. E. Frew, J.L. Wolstenholme, and D.K. Whynes Willingness-to-pay for colorectal cancer screening Eur J Cancer 37 2001 1746 1751
22. D.E. Jonas, L.B. Russell, and J. Chou Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy Health Econ 19 2010 1193 1211
23. M. Ryan, and V. Watson Comparing welfare estimates from payment card contingent valuation and discrete choice experiments Health Econ 18 2009 389 401
24. D.K. Whynes, E. Frew, and J.L. Wolstenholme A comparison of two methods for eliciting contingent valuations of colorectal cancer screening J Health Econ 22 2003 555 574
25. E.J. Frew, D.K. Whynes, and J.L. Wolstenholme Eliciting willingness to pay: comparing closed-ended with open-ended and payment scale formats Med Decis Making 23 2003 150 159
26. E.J. Frew, J.L. Wolstenholme, and D.K. Whynes Comparing willingness-to-pay: bidding game format versus open-ended and payment scale formats Health Policy 68 2004 289 298
27. F. Norstrom, A. Ivarsson, and L. Lindholm Parents' willingness to pay for coeliac disease screening of their child J Pediatr Gastroenterol Nutr 52 2011 452 459
28. L.A. Prosser, J.A. Ladapo, and D. Rusinak Parental tolerance of false-positive newborn screening results Arch Pediatr Adolesc Med 162 2008 870 876
29. D.A. Regier, J.M. Friedman, and N. Makela Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children Clin Genet 75 2009 514 521
30. R.C. Carlos, H.K. Hussain, and J.H. Song Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment AJR Am J Roentgenol 179 2002 87 92
31. R.A. Hirth, B.S. Bloom, and M.E. Chernew Willingness to pay for diagnostic certainty: comparing patients, physicians, and managed care executives J Gen Intern Med 14 1999 193 195
32. R.A. Hirth, B.S. Bloom, and M.E. Chernew Patient, physician, and payer perceptions and misperceptions of willingness to pay for diagnostic certainty Int J Technol Assess Health Care 16 2000 35 49
33. D.M. Levitt Let the consumer decide? The regulation of commercial genetic testing J Med Ethics 27 2001 398 403
34. B.S. Uzochukwu, O.E. Onwujekwe, and N.P. Uguru Willingness to pay for rapid diagnostic tests for the diagnosis and treatment of malaria in southeast Nigeria: ex post and ex ante Int J Equity Health 9 2010 1
35. A.B. Caughey, A.E. Washington, and V. Gildengorin Assessment of demand for prenatal diagnostic testing using willingness to pay Obstet Gynecol 103 2004 539 545
36. H. Yasunaga, H. Ide, and T. Imamura Benefit evaluation of mass screening for prostate cancer: willingness-to-pay measurement using contingent valuation Urology 68 2006 1046 1050
37. S.S. Raab, D.M. Grzybicki, and A.R. Hart Willingness to pay for new Papanicolaou test technologies Am J Clin Pathol 117 2002 524 533
38. I.M. Kopits, C. Chen, and J.S. Roberts Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility Genet Test Mol Biomarkers 15 2011 871 875
39. S. Nayak, M.S. Roberts, and S.L. Greenspan Osteoporosis screening preferences of older adults J Clin Densitom 12 2009 279 286
40. V. Watson, M. Ryan, and E. Watson Valuing experience factors in the provision of Chlamydia screening: an application to women attending the family planning clinic Value Health 12 2009 621 623
41. S. Wordsworth, M. Ryan, and D. Skatun Women's preferences for cervical cancer screening: a study using a discrete choice experiment Int J Technol Assess Health Care 22 2006 344 350
42. T.H. Wagner, T. Hu, and G.V. Duenas Does willingness to pay vary by race/ethnicity? An analysis using mammography among low-income women Health Policy 58 2001 275 288
43. T.H. Wagner, T.W. Hu, and G.V. Duenas Willingness to pay for mammography: item development and testing among five ethnic groups Health Policy 53 2000 105 121
44. J.L. Severens, T.D. de Boo, and M.S. van Roosmalen Validity of willingness-to-pay for nondecisional diagnostic information HEPAC 1 2000 9 13
45. M.B. Stephens, R. Montefalcon, and D.A. Lane The maternal perspective on prenatal ultrasound J Fam Pract 49 2000 601 604
46. H.C. Shih, P. Chou, and S.J. Chen A community-based study of the willingness to pay associated with screening for diabetic retinopathy among type 2 diabetes in Kinmen, Taiwan J Epidemiol 17 2007 186 193
47. L.J. Appel, E.P. Steinberg, and N.R. Powe Risk reduction from low osmolality contrast media What do patients think it is worth? Med Care 28 1990 324 337
48. N. Cho Min, S. Lertmaharit, and P. Kamol-Ratanakul Ex post and ex ante willingness to pay (WTP) for the ICT Malaria Pf/Pv test kit in Myanmar Southeast Asian J Trop Med Public Health 31 2000 104 111
49. H. Yasunaga Who wants cancer screening with PET? A contingent valuation survey in Japan Eur J Radiol 70 2009 190 194
50. D.K. Whynes, J.L. Wolstenholme, and E. Frew Evidence of range bias in contingent valuation payment scales Health Econ 13 2004 183 190
51. R.A. Lacour, M.S. Daniels, and S.N. Westin What women with ovarian cancer think and know about genetic testing Gynecol Oncol 111 2008 132 136
52. F.J. Papatheofanis Willingness to pay for positron imaging for diagnostic evaluation of suspected lung cancer Clin Positron Imaging 1 1998 242
53. K. Bosompra, T. Ashikaga, and B.S. Flynn Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model Health Educ Res 16 2001 157 172
54. F.J. Papatheofanis The willingness to pay for positron emission tomography (PET): evaluation of suspected lung cancer using contingent valuation Q J Nucl Med 44 2000 191 196
55. H. Yasunaga, H. Ide, and T. Imamura Women's anxieties caused by false positives in mammography screening: a contingent valuation survey Breast Cancer Res Treat 101 2007 59 64
56. W. Liang, W.F. Lawrence, and C.B. Burnett Acceptability of diagnostic tests for breast cancer Breast Cancer Res Treat 79 2003 199 206
57. R. Schiffner, O. Wilde, and J. Schiffner-Rohe Difference between real and perceived power of dermoscopical methods for detection of malignant melanoma Eur J Dermatol 13 2003 288 293
58. M. Ryan, J. Diack, and V. Watson Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women Prenat Diagn 25 2005 1206 1211
59. D.M. Berwick, and M.C. Weinstein What do patients value? Willingness to pay for ultrasound in normal pregnancy Med Care 23 1985 881 893
60. K. Howard, and G. Salkeld Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer Value Health 12 2009 354 363
61. G.M. Petersen, E. Larkin, and A.M. Codori Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients Cancer Epidemiol Biomarkers Prev 8 1999 337 344
62. W. Ho, D.E. Broughton, and K. Donelan Analysis of barriers to and patients' preferences for CT colonography for colorectal cancer screening in a nonadherent urban population AJR Am J Roentgenol 195 2010 393 397
63. C. Donaldson, P. Shackley, and M. Abdalla Using willingness to pay to value close substitutes: carrier screening for cystic fibrosis revisited Health Econ 6 1997 145 159
64. C. Donaldson, P. Shackley, and M. Abdalla Willingness to pay for antenatal carrier screening for cystic fibrosis Health Econ 4 1995 439 452
65. Z. Miedzybrodzka, J. Semper, and P. Shackley Stepwise or couple antenatal carrier screening for cystic fibrosis? Women's preferences and willingness to pay J Med Genet 32 1995 282 283
66. P.J. Neumann, J.K. Hammitt, and C. Mueller Public attitudes about genetic testing for Alzheimer's disease Health Aff (Millwood) 20 2001 252 264
67. M. Paulis The influence of patient education by the dental hygienist: acceptance of the fluorescence oral cancer exam J Dent Hyg 83 2009 134 140
68. D.S. Grimes Value of a negative cervical smear Br Med J (Clin Res Ed) 296 1988 1363
69. A.I. Mushlin, C. Mooney, and V. Grow The value of diagnostic information to patients with suspected multiple sclerosis. Rochester-Toronto MRI Study Group Arch Neurol 51 1994 67 72
70. A.M. Fendrick, W.D. Chey, and N. Margaret Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease Am J Med 107 1999 133 136
71. P.F. Lata, N.C. Binkley, and M.E. Elliott Acceptability of pharmacy-based bone density measurement by women and primary healthcare providers Menopause 9 2002 449 455
72. G. Salkeld, M. Solomon, and L. Short Evidence-based consumer choice: a case study in colorectal cancer screening Aust N Z J Public Health 27 2003 449 455
73. K.A. Phillips, T. Maddala, and F.R. Johnson Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing Health services research 37 2002 1681 1705
74. H. Yasunaga, H. Ide, and T. Imamura The measurement of willingness to pay for mass cancer screening with whole-body PET (positron emission tomography) Annals of nuclear medicine 20 2006 457 462
75. L. Herbild, D. Gyrd-Hansen, and M. Bech Patient preferences for pharmacogenetic screening in depression Int J Technol Assess Health Care 24 2008 96 103
76. H. Yasunaga Willingness to pay for mass screening for prostate cancer: a contingent valuation survey Int J Urol 15 2008 102 105 discussion 05
77. A.C. Reed, P.L. Reiter, and J.S. Smith Gay and bisexual men's willingness to receive anal Papanicolaou testing Am J Public Health 100 2010 1123 1129
78. B. Uzochukwu, N. Uguru, and U. Ezeoke Voluntary counseling and testing (VCT) for HIV/AIDS: a study of the knowledge, awareness and willingness to pay for VCT among students in tertiary institutions in Enugu State Nigeria Health Policy 99 2011 277 284
79. H. Yasunaga, T. Sugihara, and T. Imamura Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey Urology 77 2011 1325 1329